Latest updates for Cgnx

Fresh curated links around CGNX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission
  • Is Cognyte Software a buy right now?
  • CG Oncology, Inc. (CGON) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /3 weeks ago

Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission

Read source
cantechletter.com /1 month ago

Is Cognyte Software a buy right now?

Roth Capital Partners analyst Taz Koujalgi says Cognyte Software’s (Cognyte Software Stock Quote, Chart, News, Analysts, Financials NASDAQ:CGNT) first-quarter results showed accele...

Read source
seekingalpha.com /1 month ago

CG Oncology, Inc. (CGON) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Read source
seekingalpha.com /1 month ago

Quant snapshot: Ciena, Tilly’s among top-rated names as Here Group, Oddity Tech lag

Read source
seekingalpha.com /1 month ago

Genius Group Limited (GNS) Discusses AI Treasury Strategy and Execution of Phase 1 - Slideshow

Read source
seekingalpha.com /4 weeks ago

Nexstar Media Group: Hold On To This Leading Broadcaster Until Their Merger Is Finalized

Read source
tradebrains.in /1 month ago

Smallcap Stock Jumps 9% After Goldman Sachs and Mutual Funds Acquire Stake

Synopsis: GNG Electronics has completed a key regulatory requirement by increasing public shareholding through a promoter stake sale. The move strengthens compliance with listing n...

Read source
fool.com /5 days ago

Why This Pharmaceutical Stock Jumped Close to 100% This Week

It is getting acquired by a larger firm in the sector.

Read source
seekingalpha.com /1 month ago

Cullinan Therapeutics, Inc. (CGEM) Discusses Promising Clinical Data for CLN-978 and Velinotamig in Autoimmune Diseases...

Read source
seekingalpha.com /1 week ago

Crane NXT: Priced For Perfection While Antares Masks A Decaying Core

Read source
finance.yahoo.com /1 month ago

Calix (CALX): FCC Gateway Clearance Supports a More Durable Broadband AI Platform Case

Read source
seekingalpha.com /1 week ago

Pluxee N.V. (PLXNF) Q3 2026 Sales/ Trading Statement Call - Slideshow

Read source
seekingalpha.com /3 weeks ago

Tungsten Mining NL (TGNMF) Shareholder/Analyst Call - Slideshow

Read source
seekingalpha.com /1 week ago

ON Semiconductor Is More Than A Cyclical Auto Semi

Read source
seekingalpha.com /1 month ago

Comtech Telecommunications Corp. (CMTL) Gilat Satellite Networks Ltd., - M&A Call - Slideshow

Read source
fool.com /1 month ago

Ceragon (CRNT) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 19, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Doron AraziChief Financial Officer — Ronen SteinTAKEAWAYSRevenue...

Read source
fool.com /1 month ago

Ceragon (CRNT) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATETuesday, May 19, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Doron AraziChief Financial Officer — Ronen SteinTAKEAWAYSRevenue...

Read source
finance.yahoo.com /1 month ago

Guinness Global Innovators Fund: Lam Research Corporation (LRCX) Sits at the Heart of The Semiconductor Value Chain

Read source
seekingalpha.com /1 month ago

Garmin Ltd. (GRMN) Shareholder/Analyst Call Prepared Remarks Transcript

Read source
seekingalpha.com /4 weeks ago

Nexxen International Ltd. (NEXN) Analyst/Investor Day Transcript

Read source
fool.com /1 month ago

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

Crinetics Pharmaceuticals develops oral therapies for rare endocrine diseases.

Read source
fool.com /1 month ago

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

Crinetics Pharmaceuticals develops oral therapies for rare endocrine diseases.

Read source
seekingalpha.com /1 week ago

Pluxee N.V. (PLXNF) Q3 2026 Sales/Trading Call Transcript

Read source
seekingalpha.com /1 week ago

Biggest stock movers Tuesday: CRNX, RIVN, and more

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Cgnx

seekingalpha.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

tradebrains.in

Recent coverage from public sources
Public source

cantechletter.com

Recent coverage from public sources
Public source